NYSE:BCS • US06738E2046
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BARCLAYS PLC-SPONS ADR (BCS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-07-18 | Citigroup | Downgrade | Buy -> Neutral |
| 2023-10-26 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2023-09-26 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2022-12-06 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2022-01-28 | B of A Securities | Downgrade | Buy -> Neutral |
| 2021-09-30 | Redburn Partners | Upgrade | Neutral -> Buy |
| 2021-08-04 | Goldman Sachs | Reiterate | Buy |
| 2021-07-30 | RBC Capital Markets | Reiterate | Sector Perform |
| 2021-07-29 | Deutsche Bank | Reiterate | Buy |
| 2021-07-29 | JP Morgan Cazenove | Reiterate | Overweight |
| 2021-07-28 | Berenberg Bank | Reiterate | Buy |
| 2021-07-28 | Shore Capital | Reiterate | Buy |
| 2021-07-06 | Berenberg Bank | Reiterate | Reiteration |
| 2021-06-16 | JP Morgan Cazenove | Reiterate | Overweight |
| 2021-05-30 | Berenberg Bank | Reiterate | Buy |
| 2021-05-24 | Berenberg Bank | Reiterate | Buy |
| 2021-05-19 | Jefferies | Reiterate | Buy |
| 2021-05-07 | Deutsche Bank | Reiterate | Buy |
| 2021-04-30 | Shore Capital | Reiterate | Buy |
| 2021-04-19 | Shore Capital | Reiterate | Buy |
| 2021-04-12 | Deutsche Bank | Reiterate | Buy |
| 2021-03-31 | JP Morgan Cazenove | Reiterate | Top Pick |
| 2021-03-22 | JP Morgan Cazenove | Reiterate | Overweight |
| 2021-02-23 | RBC Capital Markets | Reiterate | Sector Perform |
| 2021-02-10 | JP Morgan Cazenove | Reiterate | Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 29.106B 2.25% | 30.702B 5.48% | 33.232B 8.24% | 31.169B -6.21% | 32.519B 4.33% | 33.785B 3.89% | 34.489B 2.08% | 35.758B 3.68% | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | N/A -19.21% | N/A 9.09% | N/A 12.04% | 12.435B 13.09% | 13.553B 8.99% | 14.728B 8.67% | 15.343B 4.18% | 16.087B 4.85% | |
| Operating Margin | N/A | N/A | N/A | 39.90% | 41.68% | 43.59% | 44.49% | 44.99% | |
| EPS YoY % growth | 1.35 -6.11% | 1.63 20.59% | 2.04 25.11% | 2.27 11.14% | 2.66 17.20% | 3.01 13.32% | 2.98 -1.05% | 3.02 1.25% |
All data in GBP
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.64 10.74% | 0.63 23.90% | 0.53 5.01% | 0.43 -3.00% |
| Revenue Q2Q % growth | 8.099B 5.06% | 7.995B 11.24% | 7.582B 5.79% | 7.514B 6.17% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 3.178B 22.18% | 3.256B 40.16% | 2.631B -0.38% | 2.057B -11.18% |
All data in GBP
23 analysts have analysed BCS and the average price target is 29.58 USD. This implies a price increase of 24.63% is expected in the next year compared to the current price of 23.73.
BARCLAYS PLC-SPONS ADR (BCS) will report earnings on 2026-04-28.
The consensus EPS estimate for the next earnings of BARCLAYS PLC-SPONS ADR (BCS) is 0.64 USD and the consensus revenue estimate is 8.10B USD.
The consensus rating for BARCLAYS PLC-SPONS ADR (BCS) is 80.8696 / 100 . This indicates that analysts generally have a positive outlook on the stock.